Stock SEVION THERAPEUTICS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Sevion Therapeutics Inc OTC Bulletin Board

Equities

US81834Q1040

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for Sevion Therapeutics Inc
04-11 North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge DJ
03-13 Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to License ZKN-013 for Rare Dermatological Diseases CI

Chart calendar Sevion Therapeutics Inc

09db58f0c3a5ac5.zguhkI4Va2tJGkoo4-oIO1pq_X5hJ_gho6MTFRqCsTg.kUSU5t1SJhJ8cH5NiLJSaBMS0Dc4E8Bx6O1ed1yy-XK6cYzo7XxGHWR9OQ~a41b97a19ed78f51e9f725548f6e1d21

Upcoming events on Sevion Therapeutics Inc

06/08/2024 Q2 2024 Earnings Release (Projected)
06/11/2024 Q3 2024 Earnings Release (Projected)

Past events on Sevion Therapeutics Inc

08/05/2024 Q1 2024 Earnings Release (Projected)
13/11/2023 21:15 Q3 2023 Earnings Release
14/08/2023 13:30 Q2 2023 Earnings Release
27/06/2023 16:30 Investor Day - Key Opinion Leader
22/06/2023 17:00 Annual General Meeting
15/05/2023 21:30 Q1 2023 Earnings Release
03/04/2023 13:00 Q4 2022 Earnings Release
13/03/2023 16:00 Oppenheimer Healthcare Conference
01/12/2022 Reverse Split: 1 of 40
30/11/2022 15:00 Extraordinary Shareholders Meeting
10/11/2022 22:15 Q3 2022 Earnings Release
14/09/2022 21:30 ELX-02 in Class 1 Cystic Fibrosis Phase 2 Trial Results Call
15/08/2022 13:00 Interim 2022 Earnings Release
15/06/2022 18:00 Annual General Meeting
10/05/2022 13:00 Q1 2022 Earnings Release
31/03/2022 12:00 FY 2021 Earnings Release
09/01/2022 H.C. Wainwright BIOCONNECT Virtual Conference
17/11/2021 13:30 ELX-02 Phase 2 Clinical Trial Results Call
09/11/2021 13:00 Q3 2021 Earnings Release
12/10/2021 15:00 Business Update Call

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022 2023
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-47,6
-44,6
-6.75%		-50,6
-53,1
4.73%		-33,5
-36,3
7.9%		-66,0
-65,1
-1.4%		-34,4
-35,0
1.66%
0,00

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-47,1
-44,5
-5.64%		-50,9
-53,3
4.56%		-34,6
-37,3
7.3%		-66,7
-64,8
-3.01%		-36,1
-36,5
1.19%
0,00

Net income
Million USD		Released
Forecast
Spread 		-47,2
-44,5
-5.92%		-50,9
-53,3
4.56%		-34,6
-37,3
7.3%		-66,7
-64,8
-3.01%		-36,1
-36,5
1.19%
0,00

EPS
USD		Released
Forecast
Spread 		-58,0
-55,4
-4.72%		-53,6
-55,8
3.98%		-34,4
-37,0
7.03%		-38,0
-37,6
-1.06%		-666
-16,6
-3902.4%
-7,91

Announcement Date08/03/1906/03/2012/03/2130/03/2231/03/23-

Quarterly results

Fiscal PeriodDecember 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
3,50
- 		0,00
2,33
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,70
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-10,2
-10,5
2.46%		-11,6
-10,7
-8.54%		-11,0
-7,31
-49.86%		-10,3
-8,82
-16.67%		-7,14
-9,50
24.82%		-6,03
-6,61
8.79%		-5,48
-5,30
-3.45%		-4,14
-5,00
17.2%		-3,64
-4,00
9.08%


Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-9,89
-10,8
8.81%		-12,1
-10,4
-15.92%		-11,6
-7,43
-56.45%		-10,6
-9,17
-15.84%		-7,51
-9,90
24.16%		-6,32
-6,75
6.44%		-6,23
-5,60
-11.25%		-4,34
-5,30
18.09%		-3,59
-4,40
18.36%


Net income
Million USD		Released
Forecast
Spread 		-9,89
-10,8
8.08%		-12,1
-10,4
-15.92%		-11,6
-7,43
-56.45%		-10,6
-9,17
-15.84%		-7,51
-9,90
24.16%		-6,32
-6,75
6.44%		-6,23
-5,60
-11.25%		-4,34
-5,30
18.09%		-3,59
-4,40
18.36%


EPS
USD		Released
Forecast
Spread 		-4,40
-5,40
18.52%		-4,00
-4,80
16.67%		-5,20
-3,70
-40.54%		-4,80
-4,13
-16.13%		-3,60
-4,40
18.18%		-3,05
-2,97
-2.69%		-2,88
-2,55
-12.94%		-1,96
-1,54
-27.27%		-1,31
-1,97
33.5%
-1,43

Announcement Date08/11/2130/03/2206/05/2212/08/2210/11/2231/03/2312/05/2311/08/2313/11/23-

Upcoming sector events for Sevion Therapeutics Inc

23/07/2024 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
24/07/2024 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 06:00 ARGENX SE: Q2 2024 Earnings Release
29/07/2024 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Sevion Therapeutics Inc

17/05/2024 12:00 AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
16/05/2024 12:46 BIOCON LIMITED: Q4 2024 Earnings Release
16/05/2024 06:00 ZEALAND PHARMA A/S: Q1 2024 Earnings Release
15/05/2024 13:05 THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
15/05/2024 12:00 CABALETTA BIO, INC.: Q1 2024 Earnings Release
14/05/2024 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
15/05/2024 21:01 CELCUITY INC.: Q1 2024 Earnings Release
14/05/2024 21:05 ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024 21:00 ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024 13:00 IMMUNOME, INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. ELOX Stock
  4. Stock
  5. Calendar Sevion Therapeutics Inc